Mannan-binding Lectin Associated Serine Protease 1
MASP1proteinMASP1 activates the lectin-complement pathway, driving plaque inflammation and cross-talk with coagulation.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleLectin-pathway complement activation; elevated in AMI exosomes; links innate immunity to thrombosis.
Also acts inCoagulation / thrombus
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000127241
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I44
C — confounder / Type-II44
A — assay feasibility68
E — evidence strength20
T1DI (composite)7
Specificity differential (R−C)0
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Proteomics Analysis of Five Potential Plasma-derived Exosomal Biomarkers for Acute Myocardial Infarction.Current medicinal chemistry · 2025 · PMID 39754756 · doi